CD8A and pancreatic neoplasm: The immunosuppressive effects of PD-1 and PD-L1 and their associations with CD8 cells in pancreatic cancer suggest the potential usefulness of CD8 as a biomarker for immunotherapies in PDAC [42,43,44].